EvokAI Creative Labs (OKAI.V) Osake Kurssi

EvokAI Creative Labs Inc, trading under the ticker OKAI.V with ISIN CA30053J2002, is a Canadian company headquartered in Vancouver. It operates within the Health Care sector, specifically in the Health Care industry. The company completed its initial public offering (IPO) on May 9, 2011. EvokAI Creative Labs focuses on developing innovative technologies for the healthcare sector, leveraging machine learning models to analyze medical data and derive insights aimed at enhancing health outcomes, patient experiences, drug development, and clinical decision-making. The company's AI algorithms are designed to support various stakeholders across the healthcare ecosystem, including hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations, medical professionals, patients, and healthy individuals. Its stated mission involves preventing and early detecting diseases while protecting the aging genome. The company's divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer, and EvokAI Medical. EvokAI Simulators integrates cognitive neuroscience, virtual reality, and artificial intelligence to evaluate cognitive performance and spatial perception. The company's website is https://www.evokailabs.com/.